UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial

Journal of thrombosis and haemostasis, 2015-04, Vol.13 (4), p.520-529

2015

Volltextzugriff (PDF)

Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.e193-e201

2015

Volltextzugriff (PDF)

Recommendations for assessment, monitoring and follow-up of patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.319-325

2012

Volltextzugriff (PDF)

Neonatal bleeding in haemophilia: a European cohort study

British journal of haematology, 2012-02, Vol.156 (3), p.374-382

2012

Volltextzugriff (PDF)

Anti‐A2 and anti‐A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A

Journal of thrombosis and haemostasis, 2015-04, Vol.13 (4), p.540-547

2015

Volltextzugriff (PDF)

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.383-392

2011

Volltextzugriff (PDF)

Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.e25-e27

2012

Volltextzugriff (PDF)

Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.799-805

2016

Volltextzugriff (PDF)

The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII

Journal of thrombosis and haemostasis, 2012-09, Vol.10 (9), p.1814-1822

2012

Volltextzugriff (PDF)

Are low-density lipoprotein receptor-related protein 1 or non-neutralizing antibodies predictors of FVIII in vivo recovery in haemophilia A patients?

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-11, Vol.20 (6), p.e406-e408

2014

Volltextzugriff (PDF)

Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 Suppl 1 (S1), p.1-24

2016

Volltextzugriff (PDF)

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.942-949

2010

Volltextzugriff (PDF)

ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D‐dimer assay

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1252-1255

2011

Volltextzugriff (PDF)

Simple coagulation tests improve survival prediction in patients with septic shock

Journal of thrombosis and haemostasis, 2008-04, Vol.6 (4), p.645-653

2008

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcome

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.e388-e391

2012

Volltextzugriff (PDF)

Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.707-713

2010

Volltextzugriff (PDF)

Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.700-707

2007

Volltextzugriff (PDF)

Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors

Thrombosis and haemostasis, 2011-06, Vol.105 (6), p.954-961

2011

Volltextzugriff (PDF)

Achievements, challenges and unmet needs for haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (S1), p.1-24

2016

Volltextzugriff (PDF)

More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case‐control ‘NOHA First’ study

Journal of thrombosis and haemostasis, 2006-07, Vol.4 (7), p.1640-1642

2006

Volltextzugriff (PDF)

Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation: a rebuttal

Journal of thrombosis and haemostasis, 2007-09, Vol.5 (9), p.1990-1992

2007

Volltextzugriff (PDF)

Simple coagulation tests improve early mortality prediction for patients in intensive care units who have proven or suspected septic shock

Journal of thrombosis and haemostasis, 2007-05, Vol.5 (5), p.1081-1083

2007

Volltextzugriff (PDF)

Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2178-2184

2005

Volltextzugriff (PDF)

High plasma levels of endothelial protein C receptor are associated with the risk of unexplained fetal death

Journal of thrombosis and haemostasis, 2005-02, Vol.3 (2), p.393-395

2005

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(52)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Hematology
(38)
Humans
(37)
Adult
(19)
Cardiovascular System & Cardiology
(19)
Female
(19)
Peripheral Vascular Disease
(19)
Male
(13)
Pregnancy
(13)
Hemophilia A - Immunology
(11)
Factor Viii - Immunology
(9)
Risk Factors
(9)
Case-Control Studies
(8)
Haemophilia
(8)
Life Sciences
(8)
Middle Aged
(8)
Biological And Medical Sciences
(7)
Child
(7)
Hematologic And Hematopoietic Diseases
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial

Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII

Recommendations for assessment, monitoring and follow-up of patients with haemophilia

Neonatal bleeding in haemophilia: a European cohort study

Anti‐A2 and anti‐A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII

Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients

The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII

Are low-density lipoprotein receptor-related protein 1 or non-neutralizing antibodies predictors of FVIII in vivo recovery in haemophilia A patients?

Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D‐dimer assay

Simple coagulation tests improve survival prediction in patients with septic shock

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcome

Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy

Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy

Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors

Achievements, challenges and unmet needs for haemophilia patients with inhibitors

More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case‐control ‘NOHA First’ study

Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation: a rebuttal

Simple coagulation tests improve early mortality prediction for patients in intensive care units who have proven or suspected septic shock

Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study

High plasma levels of endothelial protein C receptor are associated with the risk of unexplained fetal death

Suchergebnisse filtern